Innovative stem cell therapy offers hope for restoring muscle strength in rare, inherited muscle disorders
A consortium led by scientists from Maastricht UMC+ is starting clinical trials for an innovative stem cell therapy against genetic muscle disorders and muscle wasting in the elderly, among others. On July 13 and 28, the first two patients with a hereditary muscle disorder of the energy metabolism will receive healthy muscle stem cells from the body. It is the first ever trial worldwide using such stem cells for systemic induction of muscle mass. This offers hope for countless patients in the search for a treatment for hereditary and often very rare diseases.
Under the name Generate Your Muscle (GYM), the researchers want to promote the creation of muscle mass and tissue by using healthy, body-own muscle stem cells. According to the scientists, the use of the body's own muscle stem cells has the great advantage of avoiding the necessary risks associated with the transplantation of donor cells. The uniqueness of the trial is further that although the patients have an inherited muscle disorder of energy metabolism, their muscle stem cells have virtually no hereditary defect. These stem cells can therefore be used directly as therapy. The clinical trial must demonstrate the safety of the treatment and will provide an initial picture of the effectiveness of the procedure.
Also read
-
First-generation non-Western immigrant women more competitive than Dutch women. This and more is shown in research by Dr. Özge Gökdemir and Prof. Devrim Dumludağ of Maastricht University.
-
In the upcoming months, we’ll share tips on Instagram for our students on how to live a healthier life. Not just a random collection, but tips based on actual research happening at our faculty. The brains behind this idea are Lieve Vonken and Gido Metz, PhD candidates at CAPHRI, the Care and Public...
-
Ageing well isn’t just about physique. It also means being aware of a healthy brain. To prevent dementia, Martin van Boxtel and his colleagues from ‘Alzheimer Centrum Limburg’ founded the Maastricht Ageing Study (MAAS) 30 years ago. MAAS kept track of 2043 people over 25 years in a longitudinal...
